Athenex Inc. Common Stock (NASDAQ: ATNX)
Company Name:Athenex Inc. Common Stock
Stock Symbol:NASDAQ: ATNX
Class Period Start:08/07/2019
Class Period End (inclusive):02/26/2021
Filing Deadline:05/02/2021
According to the Complaint, Athenex, Inc. is a global clinical stage biopharmaceutical company dedicated to becoming a leader in the discovery, development, and commercialization of next generation drugs for the treatment of cancer.